Last reviewed · How we verify
Motilitone
At a glance
| Generic name | Motilitone |
|---|---|
| Also known as | DA-9701 |
| Sponsor | Samsung Medical Center |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effect of Two Prokinetics in Patients With Functional Dyspepsia (NA)
- The Comparative Analysis Between Motilitone and Gasmotin for the Symptom Relief in Gallstone Patients With Functional Dyspepsia (NA)
- Study of Motilitone to Treat Functional Dyspepsia (PHASE2)
- Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms (PHASE4)
- Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease (PHASE4)
- Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease (PHASE3)
- A Study to Demonstrate the Efficacy and Safety of Motilitone® (PHASE4)
- Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |